Ken Griffin’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12M Sell
1,998,390
-64,584
-3% -$486K ﹤0.01% 3008
2025
Q4
$14.8M Buy
2,062,974
+1,646,734
+396% +$13M ﹤0.01% 2722
2025
Q3
$4.45M Sell
416,240
-5,046,170
-92% -$49.5M ﹤0.01% 4569
2025
Q2
$52.9M Buy
5,462,410
+1,454,743
+36% +$15M 0.01% 1199
2025
Q1
$59.7M Buy
4,007,667
+4,007,315
+1,138,442% +$61.6M 0.01% 1026
2024
Q4
$5.25K Sell
352
-2,884,101
-100% -$47M ﹤0.01% 13879
2024
Q3
$55.2M Buy
2,884,453
+1,162,145
+67% +$24.1M 0.01% 1122
2024
Q2
$35.7M Sell
1,722,308
-4,454,702
-72% -$88.5M 0.01% 1436
2024
Q1
$116M Buy
6,177,010
+1,966,914
+47% +$33.8M 0.02% 614
2023
Q4
$60.7M Buy
4,210,096
+2,347,869
+126% +$31.9M 0.01% 1036
2023
Q3
$32.3M Buy
1,862,227
+920,423
+98% +$19.2M 0.01% 1437
2023
Q2
$19.6M Buy
941,804
+510,668
+118% +$11.1M ﹤0.01% 1906
2023
Q1
$10.1M Sell
431,136
-950,688
-69% -$25.5M ﹤0.01% 2804
2022
Q4
$38.6M Buy
1,381,824
+362,347
+36% +$9.26M 0.01% 1334
2022
Q3
$23.9M Buy
1,019,477
+998,554
+4,773% +$30.1M 0.01% 1704
2022
Q2
$706K Sell
20,923
-3,444
-14% -$121K ﹤0.01% 7853
2022
Q1
$851K Sell
24,367
-17,913
-42% -$613K ﹤0.01% 8079
2021
Q4
$1.29M Sell
42,280
-371,218
-90% -$12.1M ﹤0.01% 7282
2021
Q3
$13.6M Buy
413,498
+359,938
+672% +$11.5M ﹤0.01% 2587
2021
Q2
$1.62M Buy
+53,560
New +$1.76M ﹤0.01% 7127

Other funds holding OGN

Ken Griffin's OGN Position: Q1 2026 in Review

Ken Griffin reduced its Organon & Co (OGN) stake by 3.1% in Q1 2026, selling an estimated $486K and leaving 1,998,390 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #3008.

Ken Griffin first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $116M in Q1 2024. 606 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Ken Griffin held 1,998,390 shares of Organon & Co worth $12M as of Q1 2026.
  • Ken Griffin sold 64,584 Organon & Co shares in Q1 2026, an estimated $486K.
  • Organon & Co made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #3008 holding.
  • Ken Griffin first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Ken Griffin's Organon & Co position peaked at $116M in Q1 2024.
  • 606 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.